Venture Capital: Five V Invests in Lyrebird

The Five V Capital Venture Capital team is excited to announce our investment in Lyrebird Health, leading their $12 million Series A round with support from Octopus Ventures and Startmate.

Lyrebird Health is a rapidly growing Australian healthtech company transforming clinical documentation. Lyrebird's AI medical scribe listens securely to doctor-patient consultations and generates tailored clinical notes that are integrated seamlessly into EMRs like Best Practice Software and Magentus—all while keeping data securely within Australia.

With over 30,000 consults generated daily in Australia alone, Lyrebird is already alleviating administrative burden across healthcare providers. Hospitals such as Gold Coast Hospital and Health Service and Alder Hey Children's NHS Foundation Trust Children’s Hospital have reported significant improvements in efficiency, documentation quality, and clinician satisfaction.

“Our vision is global, but our mission is personal: support the people who care for people. Lyrebird is built in close partnership with clinicians. Every feature, every integration, every decision - we build it with and for the doctors and healthcare teams who use it," said founder and CEO Kai Van Lieshout.

“AI companies are hitting $1m, $5m, $10m and beyond in revenue faster than ever, but Lyrebird stands out for how they’ve done it. They’ve scaled quickly with minimal capital, and developed a go-to-market strategy that compounds without burning cash,” said Five V’s Chris Gillings.

Thank you to Corrs Chambers Westgarth for their support, and to everyone involved. Congratulations to the entire Lyrebird team – we're excited to support this next chapter.

‍